79 related articles for article (PubMed ID: 32332302)
1. 18F-PSMA 1007 Uptake in a Man With Metastatic Breast Cancer.
Marafi F; Sasikumar A; Alfeeli M; Thuruthel S
Clin Nucl Med; 2020 Jun; 45(6):e276-e278. PubMed ID: 32332302
[TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
3. 18F-PSMA-1007 Uptake in Pulmonary Lymphangitic Carcinomatosis Metastasis From Prostate Cancer.
Liu BL; Hong JJ; Tang K; Lin J; Zheng XW
Clin Nucl Med; 2021 Jul; 46(7):e355-e357. PubMed ID: 33782286
[TBL] [Abstract][Full Text] [Related]
4. Biochemical Recurrence of Prostate Cancer: Initial Results with [
Giesel FL; Will L; Kesch C; Freitag M; Kremer C; Merkle J; Neels OC; Cardinale J; Hadaschik B; Hohenfellner M; Kopka K; Haberkorn U; Kratochwil C
J Nucl Med; 2018 Apr; 59(4):632-635. PubMed ID: 29419475
[TBL] [Abstract][Full Text] [Related]
5. 18F-PSMA 1007 Uptake in Brain Metastases From Breast Cancer.
Marafi F; Sasikumar A; Alfeeli M; Fathallah W
Clin Nucl Med; 2020 Feb; 45(2):e77-e79. PubMed ID: 31693624
[TBL] [Abstract][Full Text] [Related]
6. Hürthle Cell Thyroid Adenoma Showing Avid Uptake on 18F-PSMA-1007 PET/CT.
Tang K; Wang Z; Lin J; Zheng X
Clin Nucl Med; 2020 Mar; 45(3):223-224. PubMed ID: 31876816
[TBL] [Abstract][Full Text] [Related]
7. 18F-PSMA 1007 Brain PET/CT Imaging in Glioma Recurrence.
Marafi F; Sasikumar A; Fathallah W; Esmail A
Clin Nucl Med; 2020 Jan; 45(1):e61-e62. PubMed ID: 31162269
[TBL] [Abstract][Full Text] [Related]
8. Intraindividual Comparison of
Giesel FL; Will L; Lawal I; Lengana T; Kratochwil C; Vorster M; Neels O; Reyneke F; Haberkon U; Kopka K; Sathekge M
J Nucl Med; 2018 Jul; 59(7):1076-1080. PubMed ID: 29269569
[TBL] [Abstract][Full Text] [Related]
9. 18F-PSMA-1007 PET/CT for Initial Staging of Renal Cell Carcinoma in an End-Stage Renal Disease Patient.
Marafi F; Sasikumar A; Aldaas M; Esmail A
Clin Nucl Med; 2021 Jan; 46(1):e65-e67. PubMed ID: 33181733
[TBL] [Abstract][Full Text] [Related]
10. 18F-PSMA 1007 in Suspected Renal Cell Carcinoma.
Marafi F; Sasikumar A; Al-Terki A; Alfeeli M
Clin Nucl Med; 2020 May; 45(5):377-378. PubMed ID: 32209880
[TBL] [Abstract][Full Text] [Related]
11. Detection of Diffuse Peritoneal and Omental Metastases From Prostate Cancer With 18F-PSMA-1007 PET/CT.
Ji X; Wang L; Lin J; Tang K
Clin Nucl Med; 2022 Jan; 47(1):e74-e76. PubMed ID: 34238806
[TBL] [Abstract][Full Text] [Related]
12. Impact of
Soeda F; Watabe T; Naka S; Liu Y; Horitsugi G; Neels OC; Kopka K; Tatsumi M; Shimosegawa E; Giesel FL; Hatazawa J
J Nucl Med; 2019 Nov; 60(11):1594-1599. PubMed ID: 30902876
[TBL] [Abstract][Full Text] [Related]
13. Detection of Local Relapse of Prostate Cancer With 18F-PSMA-1007.
Seifert R; Schafigh D; Bögemann M; Weckesser M; Rahbar K
Clin Nucl Med; 2019 Jun; 44(6):e394-e395. PubMed ID: 30889005
[TBL] [Abstract][Full Text] [Related]
14. Ordered subset expectation maximisation vs Bayesian penalised likelihood reconstruction algorithm in 18F-PSMA-1007 PET/CT.
Witkowska-Patena E; Budzyńska A; Giżewska A; Dziuk M; Walęcka-Mazur A
Ann Nucl Med; 2020 Mar; 34(3):192-199. PubMed ID: 31902120
[TBL] [Abstract][Full Text] [Related]
15. Intraindividual Comparison of
Dietlein F; Kobe C; Hohberg M; Zlatopolskiy BD; Krapf P; Endepols H; Täger P; Hammes J; Heidenreich A; Persigehl T; Neumaier B; Drzezga A; Dietlein M
J Nucl Med; 2020 May; 61(5):729-734. PubMed ID: 31628219
[No Abstract] [Full Text] [Related]
16. Incidental Finding of Colon Carcinoma Related to High Uptake in 18F-PSMA-1007 PET.
Arçay A; Eiber M; Langbein T
Clin Nucl Med; 2020 Jul; 45(7):561-562. PubMed ID: 32433166
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic performance of
Rahbar K; Afshar-Oromieh A; Seifert R; Wagner S; Schäfers M; Bögemann M; Weckesser M
Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2055-2061. PubMed ID: 30027419
[TBL] [Abstract][Full Text] [Related]
18. Rib Fractures Mimicking Bone Metastases in 18F-PSMA-1007 PET/CT for Prostate Cancer.
Panagiotidis E; Paschali A; Giannoula E; Chatzipavlidou V
Clin Nucl Med; 2019 Jan; 44(1):e46-e48. PubMed ID: 30371591
[TBL] [Abstract][Full Text] [Related]
19. Do 18F-FDG PET/CT findings have a relationship with histopathological and immunohistochemical factors of breast cancer in men?
Vatankulu B; Işik G; Kocael P; Kuyumcu S; Ilvan Ş; Sağer S; Halaç M; Türkmen C; Sönmezoğlu K
Nucl Med Commun; 2016 Dec; 37(12):1273-1281. PubMed ID: 27472037
[TBL] [Abstract][Full Text] [Related]
20. False-Positive 18F-PSMA-1007 and True-Negative 18F-Fluorocholine PET/CT Splenic Hemangioma.
Panagiotidis E; Paschali A; Xourgia X; Chatzipavlidou V
Clin Nucl Med; 2020 Dec; 45(12):960-961. PubMed ID: 33065626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
